In this regard, the application of proteomics in the study of key molecular pathways, such as WNT, MAPK, TGFβ, and p53, has expanded our understanding of the mechanisms driving the initiation and progression of CRC [40,41,42]. This evidence concerns the gene TGFB1 and colorectal carcinoma.